Summary Basis for Regulatory Action

First Page		Document Content
Biology Factor XIII deficiency Coagulation CSL Behring Factor X Bleeding Platelet Fibrinolysis Clinical trial Blood Anatomy Coagulation system		Summary Basis for Regulatory Action Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 165,62 KB Share Document on Facebook

	3273 Pan-Selectin Antagonist, GMI-1070 Decreases Venous Thrombosis in a Mouse Model Program: Hemostasis and Thrombosis Session: Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion Tuesday, December DocID: 1vs8t - View Document
	TECHNOLOGY OFFER Novel platelet biomarkers for detection of thrombosis risk We hereby present novel biomarkers for the detection of platelet reactivity. These new biomarkers allow the risk estimation for people having a DocID: 1v9bO - View Document
	Guidance on Platelet Transfusion for Patients With Hypoproliferative Thrombocytopenia COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER DocID: 1uSsq - View Document
	Platelet Proteomics in Chronic Myeloid Leukemia DocID: 1uEkU - View Document
	Therapeutic Use of Stem Cells and Regenerative Medicine Regenerative medicine is defined as the use of biological therapies including platelet rich-plasma, pluripotent stem cells, and multipotent stem cells to effect the DocID: 1twjI - View Document